You are here: Industry Insights > COVID-19

News List

A supply gap of more than 1 billion autodisable syringes could impact COVID-19 immunization efforts in 100 countries prnasia
November 18, 2021
New PATH modeling estimates a global market supply gap of 1.2 billion autodisable (AD) syringe safe-injection devices for COVID-19 vaccine delivery.
Repurposing a familiar drug for COVID-19 WorldPharmaNews
November 18, 2021
For the past year and a half, the COVID-19 pandemic has continued to engulf the globe, fueled in part by novel variants and the uneven distribution of vaccines.
Pfizer and MPP to expand COVID-19 oral antiviral treatment access EuropeanPharmaceuticalReview
November 18, 2021
Pfizer and the Medicines Patent Pool (MPP), a United Nations (UN)-backed public health organisation, have announced the signing of a voluntary license agreement for Pfizer’s COVID-19 oral antiviral treatment...
Pfizer seeks FDA EUA for oral antiviral pill to treat Covid-19 Pharmaceutical-Technology
November 18, 2021
Pfizer has sought Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its experimental oral antiviral pill, Paxlovid (PF-07321332; ritonavir), to treat individuals with mild-to-moderate Covid-19.
Atea to terminate Covid-19 drug development deal with Roche Pharmaceutical-Technology
November 18, 2021
Atea Pharmaceuticals has announced plans to terminate a strategic partnership with Roche to co-develop the former’s experimental oral direct-acting antiviral pill, AT-527, to treat Covid-19.
Pfizer to allow generic COVID pill in 95 countries ExpressPharma
November 18, 2021
Pfizer and the UN-backed Medicines Patent Pool announced a voluntary licence yesterday on Pfizer’s generic version of COVID pill. As the pandemic continues, and in light of the ongoing inequity in global vaccine access...
EMA Begins Evaluation of Novavax' COVID-19 Vaccine ContractPharma
November 18, 2021
Novavax, Inc. announced that European Medicines Agency (EMA) has begun its evaluation of an application for conditional marketing authorization (CMA) for its COVID-19 vaccine...
New Data Suggests More Doctors Spending Time Addressing COVID-19 Vaccine Misinformation As Compared To Six Months Ago B3Cnewswire
November 18, 2021
Sermo’s most recent COVID-19 Real Time Barometer surveyed 3,050 physicians across 26 countries and showed that while more physicians are hearing fewer concerns from patients about the side effects of the vaccine...
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines prnewswire
November 18, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII)...
COVID-19 Booster Shot Helps Vast Majority of Cancer Patients prnewswire
November 18, 2021
Most cancer patients who had no measurable immune response after being fully vaccinated for COVID-19 were helped by a third vaccine dose, according to a new study by investigators at the Montefiore Einstein Cancer Center...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page